The United States has abruptly halted funding for HIV treatment and prevention programmes in South Africa, a move that sources inside the Department of Health confirm will leave millions without access to life-saving antiretroviral drugs. The decision, handed down without warning, comes as part of a broader review of foreign aid allocations. But in the townships of Soweto and the rural clinics of KwaZulu-Natal, the consequences are anything but abstract.
Documents obtained by this newsroom show that the President's Emergency Plan for AIDS Relief (PEPFAR), which covers more than 4.2 million South Africans on antiretroviral therapy, has been frozen pending a compliance audit. The audit, demanded by the Office of Management and Budget, claims to be investigating “financial irregularities.” But insiders say it is a political stunt, driven by a faction within the State Department that sees public health funding as leverage.
“We heard nothing. Then the money stopped,” says a clinic director in Cape Town who asked not to be named for fear of reprisal. “We have patients who will die without their meds. This isn't a game.”
South Africa bears the heaviest HIV burden of any country: roughly 7.5 million people live with the virus. PEPFAR has been the backbone of the response, providing drugs that keep the virus suppressed and prevent new infections. Without it, the gains of the past two decades could be wiped out in months.
The US Embassy in Pretoria has declined to comment, referring queries to Washington. But a cable sent from the embassy last week, viewed by this reporter, warns that halting funding “will result in a rapid increase in HIV-related mortality and a resurgence of transmission rates.” It goes on to note that South Africa's own health system is “not yet capable of absorbing the burden.”
The politics are messy. South Africa has been a vocal critic of US foreign policy under the current administration, and some see this as retaliation. “It's a power play,” says a former US diplomat who worked on PEPFAR for a decade. “They are using the sick as pawns.”
Meanwhile, the clock is ticking. Existing drug supplies will run out in six to eight weeks. Advocacy groups are scrambling to plug the gap, but private donations cannot replace the $600 million annual injection from PEPFAR. “This is a death sentence for thousands,” says a doctor at a public clinic in Durban. “And for what?”
The decision has sparked fury in South Africa, with the Health Minister calling the freeze “unconscionable.” But the US shows no sign of reversing course. And as the money dries up, the bodies will begin to pile up.
This is not a policy debate. This is a body count.
